Provided by Tiger Trade Technology Pte. Ltd.

Entera Bio Ltd.

2.66
+0.16006.40%
Post-market: 2.62-0.0400-1.50%17:05 EDT
Volume:1.58M
Turnover:4.19M
Market Cap:460.18M
PE:-7.52
High:2.72
Open:2.51
Low:2.51
Close:2.50
52wk High:4.20
52wk Low:0.9100
Shares:173.00M
Float Shares:139.65M
Volume Ratio:2.57
T/O Rate:1.13%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3536
EPS(LYR):-0.2476
ROE:-138.92%
ROA:-45.98%
PB:63.33
PE(LYR):-10.74

Loading ...

Monday.com Q2 Revenue Rises as AI Focus Grows

Reuters
·
Aug 10

Plus500 H1 Revenue Rises to Three-Year High on Trading Income Growth

Reuters
·
Aug 10

Israel's Entera Bio Q2 Net Loss Widens

Reuters
·
Aug 08

Entera Bio Q2 EPS $(0.14) Misses $(0.08) Estimate

Benzinga Earnings
·
Aug 08

Entera Bio Ltd Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 08

Press Release: Entera Announces Second Quarter 2026 Financial Results and Business Updates

Dow Jones
·
Aug 08

Entera Bio Says Phase 2 Post-Hoc Analysis Supports Anabolic Effect of Oral EB613 in High-Risk Postmenopausal Osteoporosis Patients

Reuters
·
Aug 04

Entera Bio Phase 2 Data Supporting EB613’s (Oral PTH(1-34)) Anabolic Effect on Postmenopausal Women with Osteoporosis at High Risk for Fracture Selected for Plenary Poster Session Presentation at the ASBMR 2026 Annual Meeting

GlobeNewswire
·
Aug 04

Entera Bio Ltd Expected to Post a Loss of 8 Cents a Share - Earnings Preview

Reuters
·
Aug 04

Entera Bio CEO Joins Canaccord Genuity Annual Growth Conference Fireside Chat

Reuters
·
Aug 01

NASDAQ Trade Halt Volatility Trading Pause at 09:57 Am

Reuters
·
Jul 27

Entera Bio Prices USD 275 Million Private Placement at USD 2.04 Per Share

Reuters
·
Jul 27

Entera Bio Leads Our Top 3 Penny Stocks To Consider

Simply Wall St.
·
Jul 22

Entera Bio Shareholders Approve Authorized Share Increase at Annual Meeting

Reuters
·
Jul 17

America’s Osteoporosis Crisis and the Oral Peptide Player You Should Watch (NASDAQ: ENTX)

TIPRANKS
·
Jul 08

3 Promising Penny Stocks With Market Caps Under $600M

Simply Wall St.
·
Jun 23

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:17 PM

Reuters
·
Jun 23

Entera Bio Advances Oral Osteoporosis Drug EB613 With Positive FDA Feedback

MT Newswires Live
·
Jun 22

Entera Bio gets FDA backing for 12-month Phase 3 EB613 osteoporosis trial in 750 women

Reuters
·
Jun 22

After Novo Nordisk’s Oral Peptide Playbook Made History – Could Entera be The Next Big Peptide Story?

TIPRANKS
·
Jun 18